News
Apr-29
Posted under: Research
Engrammatic Assessment Ready
Today Gemini Somatics announces that it has progressed far enough in its skill and personality insertion studies to begin assessment of engrammatic readings. Dr Edward Darmos, executive director of synthetic somatology, said, “It’s a mark of our dedication to the process that we have progressed so far, so quickly. Now, it’s up to us to seize that momentum and bring our understanding of synthetic somatology to its peak.”
In addition to our usual call for skilled and interesting people to offer their engrams, Gemini Somatics will be seeking sufferers of blunted affect and anhedonia. In order to eliminate the risk of infantilism or catatonia in synthetic humans, we need to build up a database of conditions that can smooth out this transition.
Gemini Somatics will be seeking volunteers to have waking-state REM readings taken in order to develop functional engrammatic information for the process of somatic synthesis.
Nov-12
Posted under: Miscellaneous
Gemini Somatics Receives New Investment
The Gemini Somatics Corporation is excited to announce a new initiative guaranteeing significant investment in several key areas of medical research.
Resources will be drawn from the Gemini Somatics Research Fund, through private investors, and federal grants. Primary fields of study include synthetic somatology, stem cell research, neuropsychology and integrated memory encoding and storage.
We are confident that this fresh injection of funds will finally allow the medical research community to push through several persistent barriers in our current capacity to understand and replicate higher brain functions, amongst other challenges. The resulting technologies will provide profound and global benefits.
We are proud to continue our tradition of leading the market in medical innovation. For more details, please contact our press department.
Oct-24
Posted under: Facilities
Gemini Somatics Funds Local School
Gemini Somatics is pleased to announce that it is providing additional funding for local schools near our extensive Oregon facility. Communications director Ellen Brayford said, "Moving forward, Gemini Somatics will provide the best education that money can buy for the local community's most important members - its children. With our extensive onsite medical facilities, we will grant access to the most advanced private health care facility in the state, free of charge, for pupils enrolled in our 'enhanced education' campaign, as healthy bodies make healthy minds".
Local education officials are being contacted to discuss how to best deploy this funding.
Sep-14
Posted under: Staff
Jane Smith Memorial Service
The Gemini Somatics Corporation wishes to express its sincere condolences to the family of Jane Smith. Her passing was tragic and untimely. We will be extending every possible assistance to her husband and three children at this difficult time.
A full service will be conducted, paid for by Gemini Somatics, on October 2nd.
Archive
Aug-01
Posted under: Research
Gene Synthesis Advancements
Building on research conducted over the last eleven years by Dr. Edward Darmos, PhD DSc, the Gemini Somatics Corporation today announced a major breakthrough in synthetic somatology.
Thanks to the tireless dedication of Dr. Darmos and his team, we have patented new, proprietary technologies which allow for dramatic acceleration of the gene synthesis process. A complete human genome, artificially generated, was inserted into a cell, which began replicating - all in just over an hour. The previous standard was three days.
The implications are, of course, extremely exciting, and our full report will be published in the usual medical journals shortly. Congratulations again to Dr. Darmos!
Jun-04
Posted under: Staff
Ellen Brayford Announced as Communications Director
Gemini Somatics are pleased to announce the appointment of Ellen Brayford to the newly created position of Communications Director.
Ellen Brayford said, "Joining Gemini Somatics was simply a once-in-a-lifetime opportunity for me to move laterally into a field I am personally very passionate about. It's a genuine honor to join such a company with rare integrity, courage and commitment to an extremely noble cause."
A very warm welcome to Ellen - we look forward to cementing our position as world leader in synthetic somatology research with her invaluable assistance.
Feb-29
Posted under: Facilities
New Oregon Office
Gemini Somatics Corporation is pleased to announce that they will be transferring their headquarters to a new 340 acre campus in Oregon later this year.
The bespoke facilities will boast cutting-edge technology, including next-generation flow cytometers and DNA sequencers, and gives them the space and resources they need to keep pushing our understanding of human nature to the next level.
Jan-11
Posted under: Press
Gemini Acquitted
A grand jury today ruled that the self-described 'Guardians of Ethical Medicine' must henceforth drop all criminal charges against the Gemini Somatics Corporation.
At the conclusion of the trial, which lasted seven months, and during which Gemini Somatics showed complete transparency of all financial records and research practices, Judge Reynoldson announced that, "there is insufficient weight behind the accusation that Gemini Somatics breached international ethical guidelines for medical research".
Gemini Somatics wish to reiterate their unflinching dedication to the strictest moral code regarding genetic research and the use of stem cells, as laid out by the United Nations.
Dec-16
Posted under: Research
Neuronet
The Gemini Somatics Corporation has taken another bold leap into the future with their latest innovation in the field of synthetic somatology - the neuronet.
Specifics will be revealed at a later date, but the current prototype is capable of analyzing and transferring previously unheard of quantities of neurological data from donor tissue.
The neuronet is a huge step towards the eventual goal of reliably assigning an adult personality and capabilities to synthetic tissue, and confirms Gemini Somatics as undisputed market leader in their field.
Nov-28
Posted under: Miscellaneous
Gemini Given Third Cardinal Award
For the third time in four years, the Gemini Somatics Corporation has been awarded the prestigious Cardinal Award for Outstanding Contribution to the Advancement of Medical Knowledge.
We are humbled and extremely grateful for the board's recognition of our successes over the past year, and vow to exceed expectations once again over the next.
As is traditional, the cash prize attached to the award has been given to a variety of charitable foundations.
Jul-17
Posted under: Research
Gemini Somatics Reveals Research
Gemini Somatics went public today with their latest developments in synthetic somatology. Previously classified medical research has been released with its current findings as part of the clinical trial recruitment phase. In conjunction with a number of other medical research organizations and funded by several government grants, Gemini Somatics has many years of research evidence proving that it is on the cusp of unlocking human potential through the emerging science of synthetic somatology.
Volunteer medical trials will be administered by the Clinical Research Association, a subsidiary of the Gemini Somatics Corporation.
